Dynasil Announces Dr. Gerald Entine as New Director
June 29, 2009
WEST BERLIN, N.J.--(BUSINESS WIRE)--Dynasil Corporation
of America (OTCBB:DYSL.OB) announced today that Dr.
Gerald Entine, Founder and President of its wholly
owned subsidiary Radiation Monitoring Devices, Inc.
("RMD") has joined the Dynasil Board of
Directors.
Dr. Entine brings to the board more than 40 years
of experience in optics, nuclear sensors and instruments.
He received his B.Sc. in Physics/Biophysics, M.A.
in Physics from the University of Pennsylvania and
he received his Ph.D. in Physics from the University
of California at Berkeley under the direction of two
Nobel Laureates - Dr. Melvin Calvin and Dr. Owen Chamberlain.
Dynasil Chairman, Mr. James Saltzman stated that:
"With the growth that we are experiencing in our contract
research and the vast potential that we see from the
commercialization of the resulting technologies, we
welcome Dr. Entine and look forward to his contribution
to the Board." Dynasil CEO, Mr. Craig Dunham,
added, "Under Dr. Entine’s guidance, we have
achieved above twenty percent growth in contract research
awarded from July 2008 through June 2009 as compared
to the previous twelve months. Commercialization of
our technology portfolio has become a major focus
and we are planning to accomplish this while maintaining
our uninterrupted record of significant and profitable
growth."
About Dynasil: Dynasil has achieved profitable growth
from $2 million in revenues to a running rate of $35
million during the past four years. It derives the
majority of its revenue from contract research for
government and private industry and is a manufacturer
of specialized instruments and products for a broad
range of applications markets in the medical, industrial,
and homeland security/ defense sectors.
This news release may contain forward-looking statements
usually containing the words "believe",
"expect", "work", "plan",
or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act. Future results of
operations, projections, and expectations, which may
relate to this release, involve certain risks and
uncertainties that could cause actual results to differ
materially from the forward-looking statements. Factors
that would cause or contribute to such differences
include, but are not limited to, the factors detailed
in the Company's Annual Report or Form 10-KSB and
in the Company's other Securities and Exchange Commission
filings, continuation of existing market conditions
and demand for our products and services.
Contact:
Dynasil Corporation of America
Patty Kehe
607-272-3320, ext. 26
pkehe@DynasilCorp.com
|
